Low Molecular Weight Heparin Therapy

Gathers the clinical studies. This book reviews the different biochemical properties, and assesses the therapeutic efficacy of low molecular weight heparins. It compares the benefits of LMWHs prophylaxis with the risk of hemorrhage; and more. It is for anesthesiologists, surgeons, primary care physicians, internists, cardiologists, and others.

---

Each section is followed with expert commentary and a critical evaluation of the studies under consideration!
This reference, unique in format, gathers the most relevant clinical studies, reviews the different biochemical properties, and assesses the therapeutic efficacy of low molecular weight heparins (LMWHs) from 1985 to the present.
Presents each study on two pages-the first describes the main parameters of the study, including experimental conditions, location, number of patients, medications, surgical procedures, and anesthesia type, and the second provides a table of results based on the study's data!
With contributions from 35 leading international physicians, Low Molecular Weight Heparin Therapy
recommends treatment practices based on levels of evidence attained in the studies

questions specific therapeutic practices when researchers fail to

provides systematic documentation of the various therapeutic indications of LMWHs

compares the benefits of LMWHs prophylaxis with the risk of hemorrhage

evaluates the ease of delivery of prophylactic therapy and treatment of thromboembolic disease

favors narrative review of each study over meta-analysis

and more!
Containing hundreds of tables, and scrupulously referenced to substantiate the critical appraisals, Low Molecular Weight Heparin Therapy is a single-volume reference ideal for anesthesiologists, surgeons, primary care physicians, internists, cardiologists, hematologists, pharmacologists, epidemiologists, and medical students in these disciplines.